NCT00794196

Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care

Impact of the Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care on the Compliance to Antidepressants and Patient Wellbeing

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 179 (actual)
• Sponsor: Fundació Sant Joan de Déu · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.

Detailed description

The aim of this study is to evaluate the efficacy of a support program in community pharmacy on the improvement of the compliance to antidepressants and the clinic of typical primary care patients under normal practice circumstances. That implies that the intervention is made by pharmacists without any specific requirement that work in the community pharmacies set up in the area of study and on patients following the usual medical circuit. As well, the cost of the support program is calculated in order to set the effectiveness of the program.

Conditions

• Depression

Interventions

Type	Name	Description
BEHAVIORAL	Pharmaceutical care program for antidepressant treatment	The pharmaceutical care program is a support program for patients starting and maintaining antidepressant treatment.

Timeline

• Start date: 2008-10-01
• Primary completion: 2011-11-01
• Completion: 2012-11-01
• First posted: 2008-11-19
• Last updated: 2016-11-22
• Results posted: 2016-08-15

Locations

2 sites across 1 country: Spain